LINTEX
920106
LINGOOD
833284
NTGEC
870436
4
CG MED EQUIP.
838810
5
Jiayu Holding
300117
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -69.34%88M | -95.00%7M | -124.11%-27M | 295.00%79M | 93.33%29M | 287M | 140M | 112M | 20M | 15M |
Net income from continuing operations | 48.67%446M | 38.36%101M | -64.44%32M | 169.15%253M | 39.53%60M | --300M | --73M | --90M | --94M | --43M |
Operating gains losses | -341.18%-225M | -122.22%-40M | 128.57%2M | -878.95%-186M | 85.71%-1M | ---51M | ---18M | ---7M | ---19M | ---7M |
Depreciation and amortization | 8.39%168M | 4.65%45M | 7.69%42M | 16.22%43M | 5.56%38M | --155M | --43M | --39M | --37M | --36M |
Deferred tax | 0.00%-13M | 72.73%-6M | --0 | -133.33%-2M | -150.00%-5M | ---13M | ---22M | --5M | --6M | ---2M |
Other non cash items | -159.79%-252M | -183.87%-88M | -133.33%-77M | -156.52%-59M | -180.00%-28M | ---97M | ---31M | ---33M | ---23M | ---10M |
Change In working capital | -783.33%-53M | -110.42%-10M | -272.22%-31M | 134.67%26M | 15.56%-38M | ---6M | --96M | --18M | ---75M | ---45M |
-Change in receivables | 733.33%38M | -115.00%-3M | 200.00%26M | 80.77%-5M | -23.08%20M | ---6M | --20M | ---26M | ---26M | --26M |
-Change in prepaid assets | -2,300.00%-24M | -57.14%3M | -200.00%-15M | -350.00%-5M | -40.00%-7M | ---1M | --7M | ---5M | --2M | ---5M |
-Change in payables and accrued expense | 291.18%65M | 600.00%10M | 366.67%28M | 157.14%16M | 210.00%11M | ---34M | ---2M | --6M | ---28M | ---10M |
-Change in other current assets | 109.09%2M | 425.00%21M | 0.00%-16M | 357.14%18M | -600.00%-21M | ---22M | --4M | ---16M | ---7M | ---3M |
-Change in other current liabilities | -306.45%-64M | -122.95%-14M | -125.49%-13M | 181.25%13M | 23.08%-50M | --31M | --61M | --51M | ---16M | ---65M |
-Change in other working capital | -369.23%-70M | -550.00%-27M | -612.50%-41M | ---11M | -25.00%9M | --26M | --6M | --8M | --0 | --12M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -69.34%88M | -95.00%7M | -124.11%-27M | 295.00%79M | 93.33%29M | --287M | --140M | --112M | --20M | --15M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 438.10%226M | 112.07%7M | -255.88%-53M | 883.33%295M | -163.89%-23M | 42M | -58M | 34M | 30M | 36M |
Net PPE purchase and sale | -823.53%-157M | -205.56%-38M | -89.29%-53M | -207.14%-43M | -109.09%-23M | ---17M | --36M | ---28M | ---14M | ---11M |
Net business purchase and sale | --0 | --0 | --0 | --0 | --0 | --45M | ---10M | --14M | ---2M | --43M |
Net other investing changes | 2,635.71%383M | 153.57%45M | --0 | ---- | ---- | --14M | ---84M | --91M | --3M | --4M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 438.10%226M | 112.07%7M | -255.88%-53M | 883.33%295M | -163.89%-23M | --42M | ---58M | --34M | --30M | --36M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -166.00%-532M | 54.09%-101M | -201.60%-190M | -1,642.86%-122M | 25.63%-119M | -200M | -220M | 187M | -7M | -160M |
Net issuance payments of debt | --0 | --0 | --0 | --0 | --0 | --98M | --0 | --261M | ---3M | ---160M |
Net common stock issuance | -102.28%-532M | 53.46%-101M | -313.04%-190M | ---122M | ---119M | ---263M | ---217M | ---46M | --0 | --0 |
Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---35M | ---3M | ---28M | ---- | ---- |
Cash from discontinued financing activities | 0 | |||||||||
Financing cash flow | -166.00%-532M | 54.09%-101M | -201.60%-190M | -1,642.86%-122M | 25.63%-119M | ---200M | ---220M | --187M | ---7M | ---160M |
Net cash flow | ||||||||||
Beginning cash position | 21.74%728M | -31.88%592M | 59.93%862M | 24.64%612M | 21.74%728M | --598M | --869M | --539M | --491M | --598M |
Current changes in cash | -268.99%-218M | 36.96%-87M | -181.08%-270M | 486.05%252M | -3.67%-113M | --129M | ---138M | --333M | --43M | ---109M |
Effect of exchange rate changes | -600.00%-5M | --0 | --0 | -140.00%-2M | -250.00%-3M | --1M | ---3M | ---3M | --5M | --2M |
End cash Position | -30.63%505M | -30.63%505M | -31.88%592M | 59.93%862M | 24.64%612M | --728M | --728M | --869M | --539M | --491M |
Free cash flow | -137.10%-69M | -133.70%-31M | -195.24%-80M | 500.00%36M | 50.00%6M | --186M | --92M | --84M | --6M | --4M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |